Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World Study

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma worldwide and particularly in Africa, where the incidence of HIV is the highest in the world. R-CHOP is the standard of care regimen for DLBCL, but access to rituximab is limited in developing coun...

Descripción completa

Detalles Bibliográficos
Autores principales: Musimar, Zola, Mpetani, Mtonga, Abramson, Jeremy S, Chabner, Bruce A, Mohamed, Zainab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485283/
https://www.ncbi.nlm.nih.gov/pubmed/37053476
http://dx.doi.org/10.1093/oncolo/oyad069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485283/
https://www.ncbi.nlm.nih.gov/pubmed/37053476
http://dx.doi.org/10.1093/oncolo/oyad069

Ejemplares similares